Does CBD cause addiction? What science says and why myths circulate on the internet

One of the most common questions about CBD is about addiction. "It's from hemp, so it must be addictive" — the logic seems simple, but it is flawed. CBD and THC are two different substances, even if both come from the same plant. Only THC exhibits addictive potential — CBD does not. This is not the opinion of cannabis enthusiasts or a claim from supplement manufacturers: it is the position of the World Health Organization, based on dozens of clinical studies. This article explains why CBD is not addictive, where the myth comes from, and what science says about CBD in the context of addiction therapy — because the results are truly surprising.

KEY INFORMATION
• In its 2018 report, the WHO clearly stated: “CBD does not exhibit addictive potential and is not associated with significant adverse effects.”
• CBD does not directly bind to CB1 receptors in the reward system — a key mechanism of THC addiction. CBD does not activate the dopaminergic reward pathway.
• No tolerance: CBD does not require a constant increase in dosage to achieve the same effect — unlike opioids, benzodiazepines, and alcohol.
• Research paradox: CBD may help in treating addictions to alcohol, opioids, and tobacco by modulating 5-HT1A and the endocannabinoid system.
• The confusion arises from mixing up CBD with THC and from a lack of differentiation between cannabinoids in public discourse.

What WHO and science say: CBD does not cause addiction

The fundamental reference point is the 2018 report from the WHO Expert Committee on Drug Dependence. The organization stated directly: “CBD does not show indicators of abuse potential or dependence in human studies.” This assessment is based on a review of over 50 clinical and preclinical studies involving various populations and dosages.

Why doesn't CBD cause addiction? The key is the molecular mechanism. Addiction would require the substance to directly activate CB1 receptors in the limbic system (reward, motivation, emotions) — just as THC does. CBD does not directly bind to CB1; moreover, at higher concentrations, it acts as a CB1 antagonist — inhibiting its activation by other ligands. It does not activate the dopaminergic reward system in a way characteristic of addictive substances.

The three criteria of addiction — tolerance, physical dependence, and compulsive substance-seeking — have not been confirmed for CBD in any clinical study. Studies with Epidiolex (the only FDA-approved CBD medication, used by children and adults with epilepsy for years) showed no tolerance or withdrawal symptoms after dose reduction.

Where does the myth of CBD addiction come from?

The myth has several layers, each of which is understandable from a sociological perspective:

Association with marijuana: CBD comes from the Cannabis sativa plant — the same one from which marijuana is derived. Marijuana (due to THC) has a documented addictive potential. In popular discourse, the equation “cannabis = drug = addiction” is a simplification that ignores the pharmacology of individual components. It’s a bit like claiming that all grape products are addictive because wine contains alcohol.

Lack of differentiation between cannabinoids in the media: Headlines rarely distinguish CBD from THC. “Compound from marijuana” is a clickable term that requires no explanation — but it creates a false image. When positive information about CBD appears, an article about marijuana addiction often accompanies it, leading the reader to connect these two messages.

Anti-cannabis campaigns: Decades of the narrative “drugs = dangerous and addictive” have created strong associations that are difficult to reverse even in the face of scientific data. Some organizations, due to ideological or political beliefs, maintain the alarm, failing to distinguish CBD from other cannabinoids. This is not malice — it’s the effect of built-in associative framing that requires active cognitive effort to break.

Lack of patient education by doctors: Many doctors in Poland have outdated information about CBD or deliberately avoid the topic, not wanting to “legitimize drugs.” Patients who do not receive reliable information from specialists are left to rely on the Internet — where myths and facts mix in an unorganized pile. Conversations with doctors “about CBD” too often end with a firm “this is marijuana, I do not recommend it” without delving into the pharmacology of cannabidiol as a separate substance.

Our observations: In practice, we often encounter the opposite problem — not addiction to CBD, but irregular use due to fear of addiction. Paradoxically, this concern leads to ineffective supplementation: CBD works best with regular use over 4–8 weeks. Interrupting every few days 'to avoid addiction' negates the therapeutic effects.

CBD and tolerance: do you need more over time?

Tolerance — the need to increase the dose to achieve the same effect — is one of the key mechanisms of addiction. Opioids, benzodiazepines, and alcohol cause tolerance through receptor regulation (down-regulation): the body reduces the number or sensitivity of receptors in response to constant stimulation. Building tolerance leads to dose escalation and physical dependence.

CBD works differently. Clinical studies with Epidiolex (CBD at doses up to 20 mg/kg/day for 2 years) have shown that the therapeutic effect was maintained without the need to increase the dose throughout the observation period. Some researchers even suggest a reverse mechanism — so-called 'reverse tolerance': with regular use of CBD, effects may increase at the same or lower dose. The mechanism involves upregulation of endocannabinoid receptors and normalization of the ECS — which is the opposite of addiction mechanisms. This phenomenon is also observed with other phytocannabinoids, although the full mechanism is not yet explained.

Practical implication: if you use CBD regularly and after a few weeks you feel that the effect persists or even improves at the same dose — this is normal and expected. If the effect decreases, a short break (7–14 days) is usually sufficient, after which it returns with full strength. This is a completely different pattern than classic addictive substances, where a break causes withdrawal symptoms and strong cravings.

CBD and addiction treatment: reverse pharmacology

One of the most interesting research directions is the potential of CBD in addiction therapy — and here the results are intriguing. Review Bhatt et al. (Frontiers in Pharmacology, 2020) summarized clinical and preclinical data: CBD may reduce cravings in opioid, alcohol, tobacco, and methamphetamine addiction.

Mechanisms: modulation of 5-HT1A receptors reduces anxiety triggering relapses; indirect modulation of CB1 by anandamide may compensate for the dysregulation of the endocannabinoid system characteristic of addictions; CBD may reduce reactivity to cues associated with the addictive substance. One pilot clinical study showed that CBD at a dose of 400–800 mg reduced heroin cravings in abstinent individuals after exposure to drug-related cues (Hurd et al., American Journal of Psychiatry, 2019).

The substance suspected of causing addiction is simultaneously being studied as a tool for addiction treatment — this is probably the best way to illustrate how unfounded the concerns about the addictive potential of CBD are.

Long-term safety of CBD: what do we know?

The long-term safety of CBD is one of the better-studied aspects. Epidiolex is used by patients with epilepsy — including children — for years, and safety data is regularly published by the manufacturer and monitored by the FDA. The profile of adverse effects with long-term use mainly includes: drowsiness at higher doses, rarely elevated liver enzymes (ALT, AST) at very high doses (>20 mg/kg/day), mild gastrointestinal disturbances at the beginning of use.

No addiction, no tolerance, no serious adverse effects at standard supplemental doses — these are the data that make CBD one of the safer dietary supplements on the market. It is not a magic solution for everything, but concerns about addiction are unfounded and should not deter consideration of CBD as therapeutic support. For comparison: caffeine, which most Poles consume daily in coffee, has a higher addictive potential than CBD — yet no one panics at the thought of morning coffee. More about the safety of CBD and dosing can be found in the article dawkowanie CBD.

Frequently Asked Questions

Does CBD cause addiction?

No. The WHO stated unequivocally in its 2018 report that CBD does not exhibit addictive potential. CBD does not create tolerance requiring constant dose increases, does not induce withdrawal symptoms upon cessation of use, and does not lead to compulsive behaviors. This is a key difference between CBD and THC, which can induce dependence.

Why do people think CBD is addictive?

The main sources of the myth: associating CBD with marijuana and addictive THC, the indistinction of cannabinoids in popular media, and decades of anti-cannabis narrative. CBD comes from the same plant as THC, but is pharmacologically a distinct substance without addictive potential — confirmed by the WHO based on dozens of clinical studies.

Can you stop using CBD without withdrawal symptoms?

Yes. Unlike benzodiazepines, opioids, or even caffeine, CBD does not induce a withdrawal syndrome. Long-term clinical studies with Epidiolex (used for years by children with epilepsy) did not show withdrawal symptoms after cessation of administration. You can freely start and stop using CBD.

What is the difference between CBD and THC in terms of addiction?

THC directly activates CB1 receptors in the brain's reward system, which can lead to addiction with long-term use. CBD does not bind directly to CB1, does not induce euphoria, and does not activate the dopaminergic reward pathway in an addictive manner. The WHO classifies CBD as a substance without addictive potential, and THC as a substance with addictive potential.

Can CBD help in treating addictions?

Preliminary studies suggest that CBD may reduce cravings for addictive substances. The study by Hurd et al. (American Journal of Psychiatry, 2019) showed a reduction in heroin cravings after CBD in abstinent individuals. The review by Bhatt et al. (2020) indicated potential in alcohol, opioid, and tobacco addiction. CBD may be a component of comprehensive addiction therapy — not a standalone treatment.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04